EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Xlife Sciences AG's Enterprise Value is $330.73 Mil.
Xlife Sciences AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $0.32 Mil. Therefore, Xlife Sciences AG's EV-to-FCF for today is 1,023.93.
The historical rank and industry rank for Xlife Sciences AG's EV-to-FCF or its related term are showing as below:
XLSCF'
s EV-to-FCF Range Over the Past 10 Years
Min: -111.94 Med: -78.31 Max: 3945.17
Current: 1473.26
During the past 6 years, the highest EV-to-FCF of Xlife Sciences AG was 3945.17. The lowest was -111.94. And the median was -78.31.
XLSCF's EV-to-FCF is ranked worse than 98.48% of 394
companies
in the Biotechnology industry
Industry Median: 4.23
vs XLSCF: 1473.26
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Xlife Sciences AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xlife Sciences AG's EV-to-FCF
For the Biotechnology subindustry, Xlife Sciences AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xlife Sciences AG's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Xlife Sciences AG's EV-to-FCF falls into.
Xlife Sciences AG's current Enterprise Value is $330.73 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xlife Sciences AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $0.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xlife Sciences AG (GREY:XLSCF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Xlife Sciences AG's PE Ratio for today is calculated as:
Xlife Sciences AG's share price for today is $34.8138.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xlife Sciences AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Xlife Sciences AG EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Xlife Sciences AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Xlife Sciences AG (Xlife Sciences AG) Business Description
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XLSCF has been successfully added to your 